Viking Wins First Round In Legal Battle With Ascletis Over THRβ Agonist
Both Firms Pursuing MASH Candidates
The US International Trade Commission looks set to ban the importation of Ascletis's THRβ agonist into the US for use in clinical trials due to an initial legal determination on potential infringement of trade secrets related to Viking's same-class candidate VK2809.
